Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
9.35
-0.42 (-4.30%)
Apr 1, 2025, 4:00 PM EDT - Market closed

Nuvectis Pharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-19-22.26-19.09-12.89-0.02
Stock-Based Compensation
4.864.711.711.89-
Change in Accounts Payable
-0.27-0.141.851.590.02
Change in Other Net Operating Assets
2.171.741.97-0.09-
Operating Cash Flow
-12.25-15.95-13.56-9.5-
Issuance of Common Stock
12.0416.4831.88--
Other Financing Activities
-0.38-1.39-4.07--
Financing Cash Flow
11.6515.0927.8115.25-
Net Cash Flow
-0.59-0.8714.255.74-
Levered Free Cash Flow
-5.61-7.83-6.12--
Unlevered Free Cash Flow
-5.61-7.83-6.12--
Change in Net Working Capital
-1.9-1.15-3.45--
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q